Radboud Imaging Research
Welcome to the research website of the Department of Radiology and Nuclear Medicine at Radboud university medical center, Nijmegen.
Our research has a strong focus on early detection and early treatment of common diseases. It covers fundamental research on a molecular level, development of new medical devices and software tools, and translates these results to clinical applications that can be used in daily routine. Our mission is to bridge the gap between research and practice and to help shape the future of healthcare. We use technology to make healthcare more affordable by increasing automation of diagnostic and therapeutic procedures, thus freeing manpower for those areas in patient care in which the "human touch" is most needed.
The four fundamental science groups cover ultrasound (MUSIC), biomedical MR (BioMR), diagnostic image analysis (DIAG) and tracer research (TRACER). Clinical research is mainly focused on prostate, breast, chest and vascular disease.
Antibodies that block the interaction between programmed death ligand 1 (PD-L1) and PD-1 have shown impressive antitumor activity. Patients with tumors expressing PD-L1 are most likely to respond to this treatment. However, in clinical practice it is difficult to determine whether a patient’s tumor has this expression pattern. In Cancer Research, Heskamp et al. have published a technique to visualize PD-L1 expression in living tumors, paving the way for more efficient treatment of this type of cancer. Read more...
See more in the Highlight Archive.
- November 25, 2015: Bianca Lassen will defend her PhD thesis at 12:30.
- November 19, 2015: Colin Jacobs will defend his PhD thesis at 14:30
- October 22, 2015: Pragnya Maduskar will defend her PhD thesis at 10:30.
- June 23, 2015: Anton Meijer has obtained his PhD with a thesis entitled Clinical Application of Brain MRI - From basic to advanced imaging in Parkinsonism.
- May 27, 2015: Wietske Woliner-van der Weg has obtained her PhD for her thesis Clinical application of quantative SPECT in patient specific dosimetry and beta cell quantification.
- May 22, 2015: Stijn Muselaers has obtained his PhD for his thesis Targeting renal cell carcinoma with radiolabeled antibodies.
For older news, see the News Archive.